Shu-Ling Fu
Overview
Explore the profile of Shu-Ling Fu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
574
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhuang K, Chen C, Chan H, Wang S, Lee D, Chen S, et al.
Phytomedicine
. 2024 Jul;
132:155860.
PMID: 38991252
Background: Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer type that urgently requires effective therapeutic strategies. Andrographolide, a labdane diterpenoid compound abundant in Andrographis paniculata, has anticancer effects against...
2.
Yang T, Chiang Y, Chiang P, Chen H, Zhuang K, Wang Y, et al.
Bioorg Med Chem
. 2024 Jan;
98:117582.
PMID: 38171253
In this study, we explored a concise and mild synthetic route to produce novel C-14 arylcarbamate derivatives of andrographolide, a known anti-inflammatory and anticancer natural product. Upon assessing their anti-cancer...
3.
Ou S, Hsu Y, Fu S, Lin L, Lin C
Int J Mol Sci
. 2023 Dec;
24(23).
PMID: 38068895
Sepsis results from uncontrolled inflammation, characterized by cytokine storm and immunoparalysis. To assess whether galgravin, a natural lignan isolated from , can be used to treat sepsis, models of bacterial...
4.
Ping Y, Yeh H, Chu L, Lin Z, Hsu Y, Lin L, et al.
Front Pharmacol
. 2023 Sep;
14:1272615.
PMID: 37701032
[This corrects the article DOI: 10.3389/fphar.2022.744439.].
5.
Hsu Y, Ou S, Zhuang K, Kuo A, Li W, Huang C, et al.
J Tradit Complement Med
. 2023 Jul;
13(4):379-388.
PMID: 37396154
Background And Aim: Sepsis causes an uncontrolled systemic response characterized by excessive inflammation and immune suppression, leading to multiple organ failure and death. An effective therapeutic strategy for sepsis-related syndromes...
6.
Chou Y, Lin C, Hsu Y, Syu J, Tseng L, Chiu J, et al.
Biochem Pharmacol
. 2022 Nov;
206:115327.
PMID: 36330949
Triple-negative breast cancers (TNBCs) are difficult to cure and currently lack of effective treatment strategies. Cancer stem cells (CSCs) are highly associated with the poor clinical outcome of TNBCs. Thoc1...
7.
Chang K, Lin T, Fu S, Ping Y, Chen F, Kung Y
J Chin Med Assoc
. 2022 Apr;
85(6):717-722.
PMID: 35421875
Background: The symptoms of coronavirus disease 2019 (COVID-19) such as hyposmia, rhinorrhea, nasal obstruction, and cough are similar to those of chronic allergic rhinitis (AR). Such symptoms can easily lead...
8.
Ping Y, Yeh H, Chu L, Lin Z, Hsu Y, Lin L, et al.
Front Pharmacol
. 2022 Apr;
13:744439.
PMID: 35387343
COVID-19 is a global epidemic. Developing adjuvant therapies which could prevent the virus from binding to cells may impair viral infection. This study produces a traditional Chinese medicine formula, Jing...
9.
Chu Y, Yang C, Cheng M, Fu S, Chen J
Antioxidants (Basel)
. 2022 Feb;
11(2).
PMID: 35204266
The rhizome of Bunge (AA, family Liliaceae) is a famous and frequently used herbal drug in the traditional medicine of Northeast Asia, under vernacular name "zhimu". has been used as...
10.
Kuo Y, Wei S, Jiang J, Chang Y, Liu M, Fu S, et al.
Int J Mol Sci
. 2021 Nov;
22(22).
PMID: 34830455
Chronic myeloid leukemia (CML) is a hematopoietic malignancy characterized by the presence of the BCR-ABL oncogene. Therapeutic regimens with tyrosine kinase inhibitors (TKIs) specifically targeting BCR-ABL have greatly improved overall...